SCHEMBL31060468

SCHEMBL31060468

CC(=O)Oc1ccc2oc(C(=O)c3cc4cc(OC(C)=O)ccc4o3)cc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 1.00
CA2 P00918 3/20 0.65
CA12 O43570 2/20 0.63
CA9 Q16790 2/20 0.63
GAPDH P04406 4/20 0.59
KDM4E B2RXH2 2/20 0.53
GLA P06280 2/20 0.53
GAA P10253 2/20 0.53
POLB P06746 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
CLK1 P49759 1/20 0.50
DYRK1A Q13627 1/20 0.50
DYRK1B Q9Y463 1/20 0.50
MAOB P27338 2/20 0.49
PIM1 P11309 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
CASP1 P29466 1/20 0.49
BRCA1 P38398 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10929305 0.87 FLT3 (0.77) FLT3CA2CA12CA9GAPDH
SCHEMBL8696625 0.86 FLT3 (0.76) FLT3CA2CA12CA9GAPDH
SCHEMBL31060243 0.83 FLT3 (0.71) FLT3CA2CA12CA9KDM4E
SCHEMBL11750942 0.78 FLT3 (0.64) FLT3CA2CA12CA9GAPDH
SCHEMBL11464989 0.78 FLT3 (0.63) FLT3CA2CA12CA9GAPDH
SCHEMBL3825039 0.77 CA2 (0.65) FLT3CA2CA12CA9GAPDH
SCHEMBL16283612 0.77 CA12 (1.00) FLT3CA2CA12CA9GAPDH
SCHEMBL3974361 0.76 CA12 (0.65) FLT3CA2CA12CA9KDM4E
SCHEMBL30595409 0.76 CA12 (0.65) FLT3CA2CA12CA9KDM4E
SCHEMBL7962840 0.76 FLT3 (0.61) FLT3CA2CA12CA9GAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed